Baseline ,and postoperative 1 ,6 and 12 months full ophthalmic examination was done.~Procedure included intravitreal injection of Brolucizumab (BEOVU®, Genen-tech, South Francisco, CA)
Dystrophy-Related macular neovascularization degeneration occur is a vision threatening condition.The investigators evaluate the efficacy of BEOVU intravitreal treatment.